NCT02057822|Unknown
Loading search results
Sponsor study identifier
Secondary identifiers
observational
60
1 country
1
Study Start
November 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The ocular surface may be the seat of an inflammatory process in many pathology as vernal keratoconjunctivitis. It has been shown that inflammatory cytokines produced by the cells themselves and the constituent cells of the target organ, are the main factors that cause inflammation. The main objective of our study was to compare the concentration of 40 cytokines in vernal keratoconjunctivitis and in control subjects.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2013
Date type not reportedThis date has not been verified as actual or estimated.
November 25, 2013
Actual (reported)February 7, 2014
Actual (reported)December 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
January 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Concentration of 40 cytokines in tears
Comparaison of concentration of 40 cytokines in tears between healthy children and children with vernal keratoconjunctivitis
at time 0
Validation of normal range of cytokines in tears of healthy children
at 6 month
Modification of the inflammatory profile according to the clinical severity and treatment
at 6 month
The main objective of our study was to compare the concentration of 40 cytokines in vernal keratoconjonctivitis and in control subjects
The main objective of our study was to compare the concentration of 40 cytokines in vernal keratoconjunctivitis and in control subjects
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
healthy children children with vernal keratoconjunctivitis
CHU de Clermont-Ferrand
Clermont-Ferrand, 63003, France
Frédéric CHIAMBARETTA
University Hospital, Clermont-Ferrand
First Submitted
November 25, 2013
First Posted
February 7, 2014
Study Start
November 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2015
Estimated (date passed)Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctivitis
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 7, 2014
Record last verified: 2014-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: